Metropolis Healthcare Q2 profit jumps 42.7% to Rs 75.5 crore

Metropolis Healthcare shares are in focus on 4 Nov 2026 after Q2 profit rose 42.7%. The chart shows higher lows, with support at 510 and resistance at 610. Metropolis Healthcare Limited [

] shares were in focus on 4 November 2026 after its Q2 consolidated results. Profit rose 42.7% year on year to Rs 75.5 crore, against Rs 52.9 crore. Revenue rose 15.8% to Rs 496.8 crore from Rs 429.2 crore. Profit grew much faster than revenue. The daily chart shows the market structure has been improving. After a deep fall from the earlier peak, price formed a base and then made a series of higher lows. The recent high near 610 was followed by a pullback, and price now trades near Rs 568.70, above the 510 support. In my view, the structure of higher highs and higher lows is intact while 510 holds, and the strong profit growth adds support. A close above 610 would bring a fresh leg higher into focus. A fall below 510 would break the higher low sequence and bring a deeper pullback in view. Watch how price reacts near 610 resistance and whether 510 holds on any dip. Stance: constructive while 510 holds, with 610 as the key resistance. Disclaimer: I do not hold any position in this. This content is for informational purposes only and is not a recommendation to buy or sell. Investments in securities are subject to market risks. Please read all related documents carefully before investing.